PPIG and cancer: CYP3A4 and CYP2C8 are closely related to paclitaxel resistance.639,640 High levels of CYP enhance the metabolism of paclitaxel, reduce its concentration in cancer cells, thus develop drug resistance, and limit therapeutic efficacy.